In the News

Share

Connect with us

Stay Informed.

Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

445 News Items found
Feature
Memorial Sloan Kettering breast cancer expert Mark Robson.
Who Should Be Tested for a BRCA Mutation? The Science Is Evolving

Though questions remain about how best to use genetic testing for cancer, the trend is toward more inclusive criteria.
Ask the Expert
Angela Katrichis speaks with a patient
The Best Ways to Cope with Active Surveillance

Learn how to cope with stress and anxiety you may feel if you are diagnosed with cancer and your doctor recommends active surveillance instead of treatment.
In the Clinic
Viviane Tabar in a white coat at a desk with a computer screen in the background
The Last Frontier in Cancer Care: Treating Disease When It Spreads to the Brain

MSK doctors and scientists are leading the charge to find new and innovative ways to treat metastatic brain cancer.
Feature
Three men standing in an airport
Exporting Expertise: How MSK Is Helping to Improve Cancer Care and Research in Ghana

Learn about a new initiative led by MSK pediatric hematologic oncologist Tanya Trippett that aims to improve cancer care and research in Ghana.
In the Lab
Pictured: Breast tumor treated with paclitaxel
Research Suggests New Drugs Could Boost the Effectiveness of Chemotherapy

Recent findings by Memorial Sloan Kettering investigators suggest it might be possible to improve the effectiveness of chemotherapy for breast cancer by combining the treatment with a new type of drug called a cathepsin inhibitor.
Dr. Yelena Janjigian hugs MSK patient Cecilia Defoe
New Gastric & Esophageal Cancer Treatment Breakthrough

There are new, FDA-authorized treatment options for people facing esophageal and gastric (stomach) cancer, thanks to clinical trials at Memorial Sloan Kettering that combined immunotherapy with standard treatments.
In the Clinic
Chemical biologist Gabriela Chiosis in a laboratory
Experimental Cancer Drug Developed at MSK Leads to New Approach for Treating Alzheimer's Disease

A family of drugs developed at MSK targets disrupted processes in cells in diseases related to aging.
Virtual community events in April
MSK Honors Minority Cancer Awareness Month with Virtual Community Events

Free, virtual programs in English and Spanish for our community.
In the Lab
Dmitriy Zamarin and Sohrab Shah
MSK Team Focuses on Resistance to Immunotherapy in Ovarian Cancer

A collaborative team from MSK has uncovered important new findings that explain why ovarian cancer does not respond to immunotherapy.